Human Usutu virus infection with atypical neurologic presentation, Montpellier, France, 2016

Emerging Infectious Diseases

Volumn 24, Issue 5, 2018, Pages 875-878

  Simonin, Yannick ^a   Sillam, Olivier ^b   Carles, Marie J ^c   Gutierrez, Serafin ^d   Gil, Patricia ^d   Constant, Orianne ^a   Martin, Marie F ^a   Girard, Gilda ^e   Van de Perre, Philippe ^a   Salinas, Sara ^a   Leparc Goffart, Isabelle ^e   Foulongne, Vincent ^a  

^a UNIV MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c NÎMES UNIVERSITY HOSPITAL   (France)

^d CIRAD   (France)

^e INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; EYE DROPS; NONSTRUCTURAL PROTEIN 5; VALACICLOVIR; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DYSGEUSIA; FACIAL NERVE PARALYSIS; FLAVIVIRUS INFECTION; FRANCE; HOSPITAL DISCHARGE; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; MAXIMUM LIKELIHOOD METHOD; PARESTHESIA; PTOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SANGER SEQUENCING; UPPER LIMB; USUTU VIRUS; VIRUS DETECTION; VIRUS KERATITIS; COMPLICATION; FLAVIVIRUS; GENETICS; ISOLATION AND PURIFICATION; PHYLOGENY; VIROLOGY;

ADRENAL CORTEX HORMONES; ADULT; ANTIVIRAL AGENTS; BLEPHAROPTOSIS; FACIAL PARALYSIS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; FRANCE; HUMANS; MALE; PHYLOGENY; RNA, VIRAL; VALACYCLOVIR;

EID: 85044966287     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2405.171122     Document Type: Article

References (15)

1. Gaibani P, Rossini G. An overview of Usutu virus. Microbes Infect. 2017;19:382–7. http://dx.doi.org/10.1016/j.micinf.2017.05.003
2. Cadar D, Lühken R, van der Jeugd H, Garigliany M, Ziegler U, Keller M, et al. Widespread activity of multiple lineages of Usutu virus, western Europe, 2016. Euro Surveill. 2017;22: pii:30452. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.4.30452
3. Pierro A, Gaibani P, Spadafora C, Ruggeri D, Randi V, Parenti S, et al. Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010–2011. Clin Microbiol Infect. 2013;19:E451–3. http://dx.doi.org/10.1111/1469-0691.12241
4. Allering L, Jöst H, Emmerich P, Günther S, Lattwein E, Schmidt M, et al. Detection of Usutu virus infection in a healthy blood donor from south-west Germany, 2012. Euro Surveill. 2012;17: pii:20341.
5. Cadar D, Maier P, Müller S, Kress J, Chudy M, Bialonski A, et al. Blood donor screening for West Nile virus (WNV) revealed acute Usutu virus (USUV) infection, Germany, September 2016. Euro Surveill. 2017;22:30501. http://dx.doi.org/10.2807/1560-7917. ES.2017.22.14.30501
6. Lecollinet S, Blanchard Y, Manson C, Lowenski S, Laloy E, Quenault H, et al. Dual emergence of Usutu virus in common blackbirds, eastern France, 2015. Emerg Infect Dis. 2016;22:2225. http://dx.doi.org/10.3201/eid2212.161272
7. Nikolay B. A review of West Nile and Usutu virus co-circulation in Europe: how much do transmission cycles overlap? Trans R Soc Trop Med Hyg. 2015;109:609–18. http://dx.doi.org/10.1093/trstmh/trv066
8. Vittecoq M, Lecollinet S, Jourdain E, Thomas F, Blanchon T, Arnal A, et al. Recent circulation of West Nile virus and potentially other closely related flaviviruses in southern France. Vector Borne Zoonotic Dis. 2013;13:610–3. http://dx.doi.org/10.1089/vbz.2012.1166
9. Scaramozzino N, Crance J-M, Jouan A, DeBriel DA, Stoll F, Garin D. Comparison of flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences. J Clin Microbiol. 2001;39:1922–7. http://dx.doi.org/10.1128/JCM.39.5.1922-1927.2001
10. Engel D, Jöst H, Wink M, Börstler J, Bosch S, Garigliany M-M, et al. Reconstruction of the evolutionary history and dispersal of Usutu virus, a neglected emerging arbovirus in Europe and Africa. MBio. 2016;7:e01938–15. http://dx.doi.org/10.1128/mBio.01938-15
11. Nikolay B, Weidmann M, Dupressoir A, Faye O, Boye CS, Diallo M, et al. Development of a Usutu virus specific real-time reverse transcription PCR assay based on sequenced strains from Africa and Europe. J Virol Methods. 2014;197:51–4. http://dx.doi.org/10.1016/j.jviromet.2013.08.039
12. Salinas S, Constant O, Desmetz C, Barthelemy J, Lemaitre J-M, Milhavet O, et al. Deleterious effect of Usutu virus on human neural cells. PLoS Negl Trop Dis. 2017;11:e0005913. http://dx.doi.org/10.1371/journal.pntd.0005913
13. Bakonyi T, Lussy H, Weissenböck H, Hornyák A, Nowotny N. In vitro host-cell susceptibility to Usutu virus. Emerg Infect Dis. 2005;11:298–301. http://dx.doi.org/10.3201/eid1102.041016
14. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, Walsh I, et al. Virus and antibody dynamics in acute west Nile virus infection. J Infect Dis. 2008;198:984–93. http://dx.doi.org/10.1086/591467
15. Eviston TJ, Croxson GR, Kennedy PG, Hadlock T, Krishnan AV. Bell’s palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015;86:1356–61. http://dx.doi.org/10.1136/jnnp-2014-309563